The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma

Knispel, S; Zimmer, L; Kanaki, T; Ugurel, S; Schadendorf, D; Livingstone, E

Livingstone, E (reprint author), Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol, Skin Canc Unit, Essen, Germany.

EXPERT OPINION ON DRUG SAFETY, 2018; 17 (1): 73

Abstract

Introduction: The introduction of BRAF and MEK inhibitors into clinical practice improved the prognosis of metastatic melanoma patients. The combinati......

Full Text Link